Endometrial hyperplasia and adenocarcinoma during tibolone (Livial) therapy.
von Dadelszen
P
P
Department of Obstetrics and Gynaecology, John Radcliffe Hospital, Oxford, UK.
Gillmer
M D
MD
Gray
M D
MD
McEwan
H P
HP
Pyper
R J
RJ
Rollason
T P
TP
Wright
A
A
D000230:Adenocarcinoma / Q000139:chemically induced* / Q000473:pathology; D000368:Aged; D004714:Endometrial Hyperplasia / Q000139:chemically induced* / Q000473:pathology; D016889:Endometrial Neoplasms / Q000139:chemically induced* / Q000473:pathology; D005260:Female; D006801:Humans; D008593:Menopause; D008875:Middle Aged; D009652:Norpregnenes / Q000009:adverse effects*
D009652:Norpregnenes; C027385:tibolone